<DOC>
	<DOCNO>NCT01163747</DOCNO>
	<brief_summary>This randomize , parallel-group , open-label study evaluate effect Actemra ( tocilizumab ) vaccination patient active rheumatoid arthritis inadequate response methotrexate inadequate clinical response intolerant treatment one anti-tumor necrosis factor ( anti-TNF ) therapy .</brief_summary>
	<brief_title>A Study Effects RoActemra/Actemra Vaccination Patients With Rheumatoid Arthritis Background Methotrexate ( VISARA )</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<mesh_term>Heptavalent Pneumococcal Conjugate Vaccine</mesh_term>
	<criteria>Adult patient , ≥ 18 &lt; 65 year age Rheumatoid Arthritis ( RA ) &gt; 6 month duration baseline ( American College Rheumatology criterion ) Willing receive immunization pneumococcal polysaccharide tetanus toxoid adsorb vaccine Previous immunization pneumococcal polysaccharide must occur ≥ 3 year baseline , tetanus contain vaccine ≥ 5 year Methotrexate therapy least 8 week prior baseline stable dose 7.525 mg/week ( oral parenteral ) Other diseasemodifying antirheumatic drug ( DMARDs ) must withdraw baseline Oral corticosteroid must stable dose &lt; 10 mg/day prednisone equivalent Body weight ≤ 150 kg screen Major surgery ( include joint surgery ) within 12 week prior baseline plan major surgery within 8 week baseline History current inflammatory joint disease rheumatic autoimmune disease RA Preexisting central nervous system demyelinate seizure disorder Active current history recurrent bacterial , viral fungal , mycobacterial infection Any major episode infection require hospitalization treatment intravenous antibiotic within 4 week prior baseline oral antibiotic within 2 week prior baseline Active tuberculosis require treatment within 3 year prior baseline Primary secondary immunodeficiency ( history currently active ) Intraarticular parenteral corticosteroid within 4 week prior baseline Previous treatment RoActemra/Actemra</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>November 2012</verification_date>
</DOC>